Ares Financial Consulting »

Vertex Pharmaceuticals Incorporated shares owned by Ares Financial Consulting

Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Ares Financial Consulting from 13F filings

Historical chart of Ares Financial Consulting investment in Vertex Pharmaceuticals Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Vertex Pharmaceuticals Incorporated held by Ares Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Ares Financial Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $107k 240 447.26

More positions owned by Ares Financial Consulting

Vanguard Total Stock Market Etf Etf (VTI)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Dimensional U.s. Targeted Value Etf Etf (DFAT)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Dimensional International Core Equity Market Etf Etf (DFAI)
Nvidia Corporation Stock (NVDA)
Avantis U.s. Equity Etf Etf (AVUS)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Pimco 15 Year Us Tips Index Exchange-traded Fund Etf (LTPZ)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Saba Closed End Funds Etf Etf (CEFS)
Vanguard Total International Stock Etf Etf (VXUS)
Apple Stock (AAPL)
Dimensional International Core Equity 2 Etf Etf (DFIC)

View all positions for Ares Financial Consulting

Top funds holding Vertex Pharmaceuticals Incorporated

Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
State Street Corporation
Geode Capital Management
Capital Research and Management Company - Division 3
Alliancebernstein
Loomis, Sayles and
Wellington Management Company
Victory Capital Management
Jennison Associates
Norges Bank Investment Management
Ubs Global Asset Management Americas
ClearBridge Advisors

View all funds holding Vertex Pharmaceuticals Incorporated